[1]
|
Bashir, M.F., Ma, B. and Shahzad, L. (2020) A Brief Review of Socio-Economic and Environmental Impact of Covid-19. Air Quality, Atmosphere & Health, 13, 1403-1409. https://doi.org/10.1007/s11869-020-00894-8
|
[2]
|
Bashir, M.F., Sadiq, M., Talbi, B., Shahzad, L. and Adnan Bashir, M. (2022) An Outlook on the Development of Renewable Energy, Policy Measures to Reshape the Current Energy Mix, and How to Achieve Sustainable Economic Growth in the Post COVID-19 Era. Environmental Science and Pollution Research, 29, 43636-43647. https://doi.org/10.1007/s11356-022-20010-w
|
[3]
|
Singh, R.P. and Chauhan, A. (2020) Impact of Lockdown on Air Quality in India during COVID-19 Pandemic. Air Quality, Atmosphere & Health, 13, 921-928. https://doi.org/10.1007/s11869-020-00863-1
|
[4]
|
Messner, W. (2020) The Institutional and Cultural Context of Cross-National Variation in COVID-19 Outbreaks. https://doi.org/10.1101/2020.03.30.20047589
|
[5]
|
Ashraf, B.N. and Goodell, J.W. (2022) COVID-19 Social Distancing Measures and Economic Growth: Distinguishing Short- and Long-Term Effects. Finance Research Letters, 47, Article ID: 102639. https://doi.org/10.1016/j.frl.2021.102639
|
[6]
|
Guerrieri, V., Lorenzoni, G., Straub, L. and Werning, I. (2022) Macroeconomic Implications of COVID-19: Can Negative Supply Shocks Cause Demand Shortages? American Economic Review, 112, 1437-1474. https://doi.org/10.1257/aer.20201063
|
[7]
|
Deltour, V., Poujol, A.L. and Laurent, A. (2023) Post-Traumatic Stress Disorder among ICU Healthcare Professionals before and after the Covid-19 Health Crisis: A Narrative Review. Annals of Intensive Care, 13, Article No. 66. https://doi.org/10.1186/s13613-023-01145-6
|
[8]
|
Su, S., Zhao, Y., Zeng, N., Liu, X., Zheng, Y., Sun, J. and Lu, L. (2023) Epidemiology, Clinical Presentation, Pathophysiology, and Management of Long COVID: An Update. Molecular Psychiatry. https://doi.org/10.1038/s41380-023-02171-3
|
[9]
|
Elyasi, F., Zarghami, M., Fariborzifar, A., Cheraghmakani, H., Shirzad, M. and Kazempour, F. (2023) The Diagnostic Dilemma in a Patient with Neuroleptic Malignant Syndrome during the COVID-19 Pandemic: A Significant Increase in Acute Phase Reactants. Clinical Case Reports, 11, e7734. https://doi.org/10.1002/ccr3.7734
|
[10]
|
Montani, D., Savale, L., Noel, N., Meyrignac, O., Colle, R., Gasnier, M. and Monnet, X. (2022) Post-Acute COVID-19 Syndrome. European Respiratory Review, 31, Article ID: 210185. https://doi.org/10.1183/16000617.0185-2021
|
[11]
|
Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., Diamond, I. and Banerjee, A. (2021) Post-Covid Syndrome in Individuals Admitted to Hospital with Covid-19: Retrospective Cohort Study. BMJ, 372, n693. https://doi.org/10.1136/bmj.n693
|
[12]
|
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M.V., McGroder, C., Stevens, J.S. and Wan, E.Y. (2021) Post-Acute COVID-19 Syndrome. Nature Medicine, 27, 601-615. https://doi.org/10.1038/s41591-021-01283-z
|
[13]
|
Liu, J., Li, Y., Liu, Q., Yao, Q., Wang, X., Zhang, H., et al. (2021) SARS-CoV-2 Cell Tropism and Multiorgan Infection. Cell Discovery, 7, Article No. 17. https://doi.org/10.1038/s41421-021-00249-2
|
[14]
|
Singh, D. and Singh, E. (2022) An Overview of the Neurological Aspects in COVID-19 Infection. Journal of Chemical Neuroanatomy, 122, Article ID: 102101. https://doi.org/10.1016/j.jchemneu.2022.102101
|
[15]
|
Zou, X., Chen, K., Zou, J., Han, P., Hao, J. and Han, Z. (2020) Single-Cell RNA-seq Data Analysis on the Receptor ACE2 Expression Reveals the Potential Risk of Different Human Organs Vulnerable to 2019-nCoV Infection. Frontiers of Medicine, 14, 185-192. https://doi.org/10.1007/s11684-020-0754-0
|
[16]
|
Bradley, B.T., Maioli, H., Johnston, R., Chaudhry, I., Fink, S.L., Xu, H., et al. (2020) Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections in Washington State: A Case Series. The Lancet, 396, 320-332. https://doi.org/10.1016/S0140-6736(20)31305-2
|
[17]
|
Gudowska-Sawczuk, M. and Mroczko, B. (2021) The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection. Journal of Clinical Medicine, 10, Article No. 2772. https://doi.org/10.3390/jcm10132772
|
[18]
|
Alipoor, S.D. and Mirsaeidi, M. (2022) SARS-CoV-2 Cell Entry beyond the ACE2 Receptor. Molecular Biology Reports, 49, 10715-10727. https://doi.org/10.1007/s11033-022-07700-x
|
[19]
|
Loh, D. and Reiter, R.J. (2022) Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19. International Journal of Molecular Sciences, 23, Article No. 8122. https://doi.org/10.3390/ijms23158122
|
[20]
|
Nishiga, M., Wang, D.W., Han, Y., Lewis, D.B. and Wu, J.C. (2020) COVID-19 and Cardiovascular Disease: From Basic Mechanisms to Clinical Perspectives. Nature Reviews Cardiology, 17, 543-558. https://doi.org/10.1038/s41569-020-0413-9
|
[21]
|
Singh, M., Bansal, V. and Feschotte, C. (2020) A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors. Cell Reports, 32, Article ID: 108175. https://doi.org/10.1016/j.celrep.2020.108175
|
[22]
|
Bailey, A.L., Dmytrenko, O., Greenberg, L., Bredemeyer, A.L., Ma, P., Liu, J., et al. (2021) SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. Basic to Translational Science, 6, 331-345. https://doi.org/10.1016/j.jacbts.2021.01.002
|
[23]
|
Weidinger, C., Hegazy, A.N., Glauben, R. and Siegmund, B. (2021) COVID-19—From Mucosal Immunology to IBD Patients. Mucosal Immunology, 14, 566-573. https://doi.org/10.1038/s41385-021-00384-9
|
[24]
|
Lin, L., Jiang, X., Zhang, Z., Huang, S., Zhang, Z., Fang, Z., et al. (2020) Gastrointestinal Symptoms of 95 Cases with SARS-CoV-2 Infection. Gut, 69, 997-1001. https://doi.org/10.1136/gutjnl-2020-321013
|
[25]
|
Braun, F., Lütgehetmann, M., Pfefferle, S., Wong, M.N., Carsten, A., Lindenmeyer, M.T., et al. (2020) SARS-CoV-2 Renal Tropism Associates with Acute Kidney Injury. The Lancet, 396, 597-598. https://doi.org/10.1016/S0140-6736(20)31759-1
|
[26]
|
Puelles, V.G., Lütgehetmann, M., Lindenmeyer, M.T., Sperhake, J.P., Wong, M.N., Allweiss, L., et al. (2020) Multiorgan and Renal Tropism of SARS-CoV-2. New England Journal of Medicine, 383, 590-592. https://doi.org/10.1056/NEJMc2011400
|
[27]
|
Su, H., Yang, M., Wan, C., Yi, L.X., Tang, F., Zhu, H.Y., et al. (2020) Renal Histopathological Analysis of 26 Postmortem Findings of Patients with COVID-19 in China. Kidney International, 98, 219-227. https://doi.org/10.1016/j.kint.2020.04.003
|
[28]
|
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A. and Li, F. (2020) Cell Entry Mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences, 117, 11727-11734. https://doi.org/10.1073/pnas.2003138117
|
[29]
|
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
|
[30]
|
Tran, S., Ksajikian, A., Overbey, J., Li, P. and Li, Y. (2022) Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review. Cells, 11, Article No. 2489. https://doi.org/10.3390/cells11162489
|
[31]
|
Melero, I., Villalba-Esparza, M., Recalde-Zamacona, B., Jiménez-Sánchez, D., Teijeira, á., Argueta, A., et al. (2022) Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients with Fatal COVID-19. Chest, 162, 1006-1016. https://doi.org/10.1016/j.chest.2022.06.007
|
[32]
|
Cesta, M.C., Zippoli, M., Marsiglia, C., Gavioli, E.M., Cremonesi, G., Khan, A., et al. (2023) Neutrophil Activation and Neutrophil Extracellular Traps (NETs) in COVID-19 ARDS and Immunothrombosis. European Journal of Immunology, 53, Article ID: 2250010. https://doi.org/10.1002/eji.202250010
|
[33]
|
Chabert, C., Vitte, A.L., Iuso, D., Chuffart, F., Trocme, C., Buisson, M., et al. (2022) AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome. International Journal of Molecular Sciences, 23, Article No. 1911. https://doi.org/10.3390/ijms23031911
|
[34]
|
Meyerholz, D.K. and Reznikov, L.R. (2022) Influence of SARS-CoV-2 on Airway Mucus Production: A Review and Proposed Model. Veterinary Pathology, 59, 578-585. https://doi.org/10.1177/03009858211058837
|
[35]
|
Michalski, J.E., Kurche, J.S. and Schwartz, D.A. (2022) From ARDS to Pulmonary Fibrosis: The Next Phase of the COVID-19 Pandemic? Translational Research, 241, 13-24. https://doi.org/10.1016/j.trsl.2021.09.001
|
[36]
|
You, J., Zhang, L., Zhang, J., Hu, F., Chen, L., Dong, Y., et al. (2020) Anormal Pulmonary Function and Residual CT Abnormalities in Rehabilitating COVID-19 Patients after Discharge. Journal of Infection, 81, e150-e152. https://doi.org/10.1016/j.jinf.2020.06.003
|
[37]
|
McDonald, L.T. (2021) Healing after COVID-19: Are Survivors at Risk for Pulmonary Fibrosis? American Journal of Physiology-Lung Cellular and Molecular Physiology, 320, L257-L265. https://doi.org/10.1152/ajplung.00238.2020
|
[38]
|
Visco, V., Vitale, C., Rispoli, A., Izzo, C., Virtuoso, N., Ferruzzi, G.J., et al. (2022) Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems. Journal of Clinical Medicine, 11, Article No. 524. https://doi.org/10.3390/jcm11030524
|
[39]
|
Seeßle, J., Waterboer, T., Hippchen, T., Simon, J., Kirchner, M., Lim, A., et al. (2022) Persistent Symptoms in Adult Patients 1 Year after Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clinical Infectious Diseases, 74, 1191-1198. https://doi.org/10.1093/cid/ciab611
|
[40]
|
Funke-Chambour, M., Bridevaux, P.O., Clarenbach, C.F., Soccal, P.M., Nicod, L.P., von Garnier, C. and Swiss COVID Lung Study Group and the Swiss Society of Pulmonology (2021) Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID. Respiration, 100, 826-841. https://doi.org/10.1159/000517255
|
[41]
|
Myall, K.J., Mukherjee, B., Castanheira, A.M., Lam, J.L., Benedetti, G., Mak, S.M., et al. (2021) Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Annals of the American Thoracic Society, 18, 799-806. https://doi.org/10.1513/AnnalsATS.202008-1002OC
|
[42]
|
Chilazi, M., Duffy, E.Y., Thakkar, A. and Michos, E.D. (2021) COVID and Cardiovascular Disease: What We Know in 2021. Current Atherosclerosis Reports, 23, Article No. 37. https://doi.org/10.1007/s11883-021-00935-2
|
[43]
|
Tedeschi, S., Giannella, M., Bartoletti, M., Trapani, F., Tadolini, M., Borghi, C. and Viale, P. (2020) Clinical Impact of Renin-Angiotensin System Inhibitors on In-Hospital Mortality of Patients with Hypertension Hospitalized for Coronavirus Disease 2019. Clinical Infectious Diseases, 71, 899-901. https://doi.org/10.1093/cid/ciaa492
|
[44]
|
Li, N., Zhu, L., Sun, L. and Shao, G. (2021) The Effects of Novel Coronavirus (SARS-CoV-2) Infection on Cardiovascular Diseases and Cardiopulmonary Injuries. Stem Cell Research, 51, Article ID: 102168. https://doi.org/10.1016/j.scr.2021.102168
|
[45]
|
Tomidokoro, D. and Hiroi, Y. (2022) Cardiovascular Implications of the COVID-19 Pandemic. Journal of Cardiology, 79, 460-467. https://doi.org/10.1016/j.jjcc.2021.09.010
|
[46]
|
Wang, K., Gheblawi, M., Nikhanj, A., Munan, M., MacIntyre, E., O’Neil, C., et al. (2022) Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries. Hypertension, 79, 365-378. https://doi.org/10.1161/HYPERTENSIONAHA.121.18295
|
[47]
|
Xu, Y., Ma, Q., Ren, J., Chen, L., Guo, W., Feng, K., et al. (2023) Using Machine Learning Methods in Identifying Genes Associated with COVID-19 in Cardiomyocytes and Cardiac Vascular Endothelial Cells. Life, 13, Article No. 1011. https://doi.org/10.3390/life13041011
|
[48]
|
Apostolidis, S.A., Sarkar, A., Giannini, H.M., Goel, R.R., Mathew, D., Suzuki, A., et al. (2022) Signaling through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19. Frontiers in Immunology, 13, Article ID: 834988. https://doi.org/10.3389/fimmu.2022.834988
|
[49]
|
Alarabi, A.B., Mohsen, A., Mizuguchi, K., Alshbool, F.Z. and Khasawneh, F.T. (2022) Co-Expression Analysis to Identify Key Modules and Hub Genes Associated with COVID-19 in Platelets. BMC Medical Genomics, 15, Article No. 83. https://doi.org/10.1186/s12920-022-01222-y
|
[50]
|
Lazzerini, P.E., Boutjdir, M. and Capecchi, P.L. (2020) COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap! Circulation, 142, 7-9. https://doi.org/10.1161/CIRCULATIONAHA.120.047293
|
[51]
|
Chang, W.T., Toh, H.S., Liao, C.T. and Yu, W.L. (2021) Cardiac Involvement of COVID-19: A Comprehensive Review. The American Journal of the Medical Sciences, 361, 14-22. https://doi.org/10.1016/j.amjms.2020.10.002
|
[52]
|
Lu, J.Y., Buczek, A., Fleysher, R., Hoogenboom, W.S., Hou, W., Rodriguez, C.J., et al. (2022) Outcomes of Hospitalized Patients with COVID-19 with Acute Kidney Injury and Acute Cardiac Injury. Frontiers in Cardiovascular Medicine, 8, Article ID: 798897. https://doi.org/10.3389/fcvm.2021.798897
|
[53]
|
Denegri, A., Sola, M., Morelli, M., Farioli, F., Tosetti, A., D’Arienzo, M., et al. (2022) Arrhythmias in COVID-19/SARS-CoV-2 Pneumonia Infection: Prevalence and Implication for Outcomes. Journal of Clinical Medicine, 11, Article No. 1463. https://doi.org/10.3390/jcm11051463
|
[54]
|
Alnima, T., Mulder, M.M., van Bussel, B.C. and Ten Cate, H. (2022) COVID-19 Coagulopathy: From Pathogenesis to Treatment. Acta Haematologica, 145, 282-296. https://doi.org/10.1159/000522498
|
[55]
|
Bansal, M. (2020) Cardiovascular Disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 247-250. https://doi.org/10.1016/j.dsx.2020.03.013
|
[56]
|
Zheng, Y.Y., Ma, Y.T., Zhang, J.Y. and Xie, X. (2020) COVID-19 and the Cardiovascular System. Nature Reviews Cardiology, 17, 259-260. https://doi.org/10.1038/s41569-020-0360-5
|
[57]
|
Strabelli, T.M.V. and Uip, D.E. (2020) COVID-19 e o Coracao. Arquivos Brasileiros de Cardiologia, 114, 598-600. https://doi.org/10.36660/abc.20200209
|
[58]
|
Ferrara, F. and Vitiello, A. (2022) Renin Angiotensin System and COVID-19 Infection. Advanced Pharmaceutical Bulletin, 12, 1-4. https://doi.org/10.34172/apb.2022.001
|
[59]
|
Kumar, V.C.S., Mukherjee, S., Harne, P.S., Subedi, A., Ganapathy, M.K., Patthipati, V.S. and Sapkota, B. (2020) Novelty in the Gut: A Systematic Review and Meta-Analysis of the Gastrointestinal Manifestations of COVID-19. BMJ Open Gastroenterology, 7, e000417. https://doi.org/10.1136/bmjgast-2020-000417
|
[60]
|
Parasa, S., Desai, M., Chandrasekar, V.T., Patel, H.K., Kennedy, K.F., Roesch, T., et al. (2020) Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. JAMA Network Open, 3, e2011335. https://doi.org/10.1001/jamanetworkopen.2020.11335
|
[61]
|
Balasubramaniam, A., Tedbury, P.R., Mwangi, S.M., Liu, Y., Li, G., Merlin, D., et al. (2023) SARS-CoV-2 Induces Epithelial-Enteric Neuronal Crosstalk Stimulating VIP Release. Biomolecules, 13, Article No. 207. https://doi.org/10.3390/biom13020207
|
[62]
|
Low, S.W., Swanson, K.L., McCain, J.D., Sen, A., Kawashima, A. and Pasha, S.F. (2020) Gastric Ischemia and Portal Vein Thrombosis in a COVID-19-Infected Patient. Endoscopy, 52, E465-E466. https://doi.org/10.1055/a-1230-3357
|
[63]
|
Zhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., et al. (2020) Digestive System Is a Potential Route of COVID-19: An Analysis of Single-Cell Coexpression Pattern of Key Proteins in Viral Entry Process. Gut, 69, 1010-1018. https://doi.org/10.1136/gutjnl-2020-320953
|
[64]
|
Penninger, J.M., Grant, M.B. and Sung, J.J. (2021) The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection. Gastroenterology, 160, 39-46. https://doi.org/10.1053/j.gastro.2020.07.067
|
[65]
|
Wais, T., Hasan, M., Rai, V. and Agrawal, D.K. (2022) Gut-Brain Communication in COVID-19: Molecular Mechanisms, Mediators, Biomarkers, and Therapeutics. Expert Review of Clinical Immunology, 18, 947-960. https://doi.org/10.1080/1744666X.2022.2105697
|
[66]
|
Zabetakis, I., Lordan, R., Norton, C. and Tsoupras, A. (2020) COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients, 12, Article No. 1466. https://doi.org/10.3390/nu12051466
|
[67]
|
Wei, X.S., Wang, X., Niu, Y.R., Ye, L.L., Peng, W.B., Wang, Z.H., et al. (2020) Diarrhea Is Associated with Prolonged Symptoms and Viral Carriage in Corona Virus Disease 2019. Clinical Gastroenterology and Hepatology, 18, 1753-1759. https://doi.org/10.1016/j.cgh.2020.04.030
|
[68]
|
Gu, J., Han, B. and Wang, J. (2020) COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology, 158, 1518-1519. https://doi.org/10.1053/j.gastro.2020.02.054
|
[69]
|
Hashimoto, T., Perlot, T., Rehman, A., Trichereau, J., Ishiguro, H., Paolino, M., et al. (2012) ACE2 Links Amino Acid Malnutrition to Microbial Ecology and Intestinal Inflammation. Nature, 487, 477-481. https://doi.org/10.1038/nature11228
|
[70]
|
Viana, S.D., Nunes, S. and Reis, F. (2020) ACE2 Imbalance as a Key Player for the Poor Outcomes in COVID-19 Patients with Age-Related Comorbidities-Role of Gut Microbiota Dysbiosis. Ageing Research Reviews, 62, Article ID: 101123. https://doi.org/10.1016/j.arr.2020.101123
|
[71]
|
de Oliveira, G.L.V., Oliveira, C.N.S., Pinzan, C.F., de Salis, L.V.V. and Cardoso, C. (2021) Microbiota Modulation of the Gut-Lung Axis in COVID-19. Frontiers in Immunology, 12, Article No. 214. https://doi.org/10.3389/fimmu.2021.635471
|
[72]
|
Francino, M.P. (2016) Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances. Frontiers in Microbiology, 6, Article No. 1543. https://doi.org/10.3389/fmicb.2015.01543
|
[73]
|
Bhayana, R., Som, A., Li, M.D., Carey, D.E., Anderson, M.A., Blake, M.A., et al. (2020) Abdominal Imaging Findings in COVID-19: Preliminary Observations. Radiology, 297, E207-E215. https://doi.org/10.1148/radiol.2020201908
|
[74]
|
Aleem, A., Mahadevaiah, G., Shariff, N. and Kothadia, J.P. (2021) Hepatic Manifestations of COVID-19 and Effect of Remdesivir on Liver Function in Patients with COVID-19 Illness. Baylor University Medical Center Proceedings, 34, 473-477. https://doi.org/10.1080/08998280.2021.1885289
|
[75]
|
Neurath, M.F. (2020) COVID-19 and Immunomodulation in IBD. Gut, 69, 1335-1342. https://doi.org/10.1136/gutjnl-2020-321269
|
[76]
|
Du, L., Cao, X., Chen, J., Wei, X., Zeng, Y., Cheng, C., et al. (2021) Fecal Occult Blood and Urinary Cytology Tests for Rapid Screening of Inflammatory Infection in the Gastrointestinal and Urological Systems in Patients with Coronavirus Disease 2019. Journal of Clinical Laboratory Analysis, 35, e23626. https://doi.org/10.1002/jcla.23626
|
[77]
|
Effenberger, M., Grabherr, F., Mayr, L., Schwaerzler, J., Nairz, M., Seifert, M., et al. (2020) Faecal Calprotectin Indicates Intestinal Inflammation in COVID-19. Gut, 69, 1543-1544. https://doi.org/10.1136/gutjnl-2020-321388
|
[78]
|
Zhu, Y., Zhang, X. and Peng, Z. (2022) Consequences of COVID-19 on the Cardiovascular and Renal Systems. Sleep Medicine, 100, 31-38. https://doi.org/10.1016/j.sleep.2022.07.011
|
[79]
|
Aroca-Martinez, G., Avendano-Echavez, L., Garcia, C., Ripoll, D., Dianda, D., Cadena-Bonfanti, A. and Musso, C.G. (2023) Renal Tubular Dysfunction in COVID-19 Patients. Irish Journal of Medical Science (1971-), 192, 923-927. https://doi.org/10.1007/s11845-022-02993-0
|
[80]
|
Faour, W.H., Choaib, A., Issa, E., Choueiry, F.E., Shbaklo, K., Alhajj, M., et al. (2022) Mechanisms of COVID-19-Induced Kidney Injury and Current Pharmacotherapies. Inflammation Research, 71, 39-56. https://doi.org/10.1007/s00011-021-01520-8
|
[81]
|
Feng, Y.F., Wang, K.P., Mo, J.G., Xu, Y.H., Wang, L.Z., Jin, C., et al. (2021) The Spatiotemporal Trend of Renal Involvement in COVID-19: A Pooled Analysis of 17 134 Patients. International Journal of Infectious Diseases, 106, 281-288. https://doi.org/10.1016/j.ijid.2021.03.082
|
[82]
|
Oweis, A.O., Alshelleh, S.A., Hawasly, L., Alsabbagh, G. and Alzoubi, K.H. (2022) Acute Kidney Injury among Hospital-Admitted COVID-19 Patients: A Study from Jordan. International Journal of General Medicine, 15, 4475-4482. https://doi.org/10.2147/IJGM.S360834
|
[83]
|
Armentano, G.M. and Carneiro-Ramos, M.S. (2022) Effect of COVID-19 on Cardiorenal Axis: Known or Unknown Universe? Brazilian Journal of Medical and Biological Research, 55, e11932. https://doi.org/10.1590/1414-431x2022e11932
|
[84]
|
Mayerhofer, T., Perschinka, F. and Joannidis, M. (2022) Akute Nierenschadigung und COVID-19: Pulmorenaler Crosstalk unter massiver Inflammation. Medizinische Klinik-Intensivmedizin und Notfallmedizin, 117, 342-348. https://doi.org/10.1007/s00063-022-00919-3
|
[85]
|
Ackermann, M., Anders, H.J., Bilyy, R., Bowlin, G.L., Daniel, C., De Lorenzo, R., et al. (2021) Patients with COVID-19: In the Dark-NETs of Neutrophils. Cell Death & Differentiation, 28, 3125-3139. https://doi.org/10.1038/s41418-021-00805-z
|
[86]
|
Adapa, S., Chenna, A., Balla, M., Merugu, G.P., Koduri, N.M., Daggubati, S.R., et al. (2020) COVID-19 Pandemic Causing Acute Kidney Injury and Impact on Patients with Chronic Kidney Disease and Renal Transplantation. Journal of Clinical Medicine Research, 12, 352-361. https://doi.org/10.14740/jocmr4200
|
[87]
|
Greco, M., De Rosa, S., Boehm, F., Spano, S., Aceto, R., Voza, A., et al. (2023) Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients. Diagnostics, 13, Article No. 317. https://doi.org/10.3390/diagnostics13020317
|
[88]
|
Temiz, M.Z., Hacibey, I., Yazar, R.O., Sevdi, M.S., Kucuk, S.H., Alkurt, G., et al. (2022) Altered Kidney Function Induced by SARS-CoV-2 Infection and Acute Kidney Damage Markers Predict Survival Outcomes of COVID-19 Patients: A Prospective Pilot Study. Renal Failure, 44, 233-240. https://doi.org/10.1080/0886022X.2022.2032743
|
[89]
|
Husain-Syed, F., Wilhelm, J., Kassoumeh, S., Birk, H.W., Herold, S., Vadász, I., et al. (2020) Acute Kidney Injury and Urinary Biomarkers in Hospitalized Patients with Coronavirus Disease-2019. Nephrology Dialysis Transplantation, 35, 1271-1274. https://doi.org/10.1093/ndt/gfaa162
|
[90]
|
Zhang, W., Liu, L., Xiao, X., Zhou, H., Peng, Z., Wang, W., et al. (2023) Identification of Common Molecular Signatures of SARS-CoV-2 Infection and Its Influence on Acute Kidney Injury and Chronic Kidney Disease. Frontiers in Immunology, 14, Article ID: 961642. https://doi.org/10.3389/fimmu.2023.961642
|
[91]
|
Yende, S. and Parikh, C.R. (2021) Long COVID and Kidney Disease. Nature Reviews Nephrology, 17, 792-793. https://doi.org/10.1038/s41581-021-00487-3
|
[92]
|
Morrow, A.J., Sykes, R., McIntosh, A., Kamdar, A., Bagot, C., Bayes, H.K., et al. (2022) A Multisystem, Cardio-Renal Investigation of Post-COVID-19 Illness. Nature Medicine, 28, 1303-1313. https://doi.org/10.1038/s41591-022-01837-9
|
[93]
|
Bansode, J., Sayed, S.A., Ahmad, S., Sinha, S., Swami, R. and Mehta, K. (2022) Acute Kidney Injury in COVID-19: Clinical Profile and Outcome. Indian Journal of Nephrology, 32, 291-298. https://doi.org/10.4103/ijn.IJN_21_21
|
[94]
|
Jansen, J., Reimer, K.C., Nagai, J.S., Varghese, F.S., Overheul, G.J., de Beer, M., et al. (2022) SARS-CoV-2 Infects the Human Kidney and Drives Fibrosis in Kidney Organoids. Cell Stem Cell, 29, 217-231. https://doi.org/10.1016/j.stem.2021.12.010
|
[95]
|
Hung, D.T., Ghula, S., Aziz, J.M.A., Makram, A.M., Tawfik, G.M., Abozaid, A.A.F., et al. (2022) The Efficacy and Adverse Effects of Favipiravir on Patients with COVID-19: A Systematic Review and Meta-Analysis of Published Clinical Trials and Observational Studies. International Journal of Infectious Diseases, 120, 217-227. https://doi.org/10.1016/j.ijid.2022.04.035
|
[96]
|
Cui, Y., Yang, Y., Lei, W., Lang, X. and Chen, J. (2021) The Clinicopathological Features of Drug-Induced Acute Kidney Injury—A Single-Center Retrospective Analysis. Annals of Translational Medicine, 9, 400. https://doi.org/10.21037/atm-20-3826
|
[97]
|
Qomara, W.F., Primanissa, D.N., Amalia, S.H., Purwadi, F.V. and Zakiyah, N. (2021) Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review. International Journal of General Medicine, 14, 8557-8571. https://doi.org/10.2147/IJGM.S332458
|
[98]
|
Izcovich, A., Siemieniuk, R.A., Bartoszko, J.J., Ge, L., Zeraatkar, D., Kum, E., et al. (2022) Adverse Effects of Remdesivir, Hydroxychloroquine and Lopinavir/Ritonavir When Used for COVID-19: Systematic Review and Meta-Analysis of Randomised Trials. BMJ Open, 12, e048502. https://doi.org/10.1136/bmjopen-2020-048502
|
[99]
|
Stein, L.K., Mayman, N.A., Dhamoon, M.S. and Fifi, J.T. (2021) The Emerging Association between COVID-19 and Acute Stroke. Trends in Neurosciences, 44, 527-537. https://doi.org/10.1016/j.tins.2021.03.005
|
[100]
|
Strauss, S.A., Seo, C., Carrier, M. and Jetty, P. (2021) From Cellular Function to Global Impact: The Vascular Perspective on COVID-19. Canadian Journal of Surgery, 64, E289. https://doi.org/10.1503/cjs.023820
|
[101]
|
Hosp, J.A., Dressing, A., Blazhenets, G., Bormann, T., Rau, A., Schwabenland, M., et al. (2021) Cognitive Impairment and Altered Cerebral Glucose Metabolism in the Subacute Stage of COVID-19. Brain, 144, 1263-1276. https://doi.org/10.1093/brain/awab009
|
[102]
|
Uncini, A., Foresti, C., Frigeni, B., Storti, B., Servalli, M.C., Gazzina, S., et al. (2021) Electrophysiological Features of Acute Inflammatory Demyelinating Polyneuropathy Associated with SARS-CoV-2 Infection. Neurophysiologie Clinique, 51, 183-191. https://doi.org/10.1016/j.neucli.2021.02.001
|
[103]
|
Bolay, H., Gül, A. and Baykan, B. (2020) COVID-19 Is a Real Headache! Headache: The Journal of Head and Face Pain, 60, 1415-1421. https://doi.org/10.1111/head.13856
|
[104]
|
Paz, C., Mascialino, G., Adana-Díaz, L., Rodríguez-Lorenzana, A., Simbana-Rivera, K., Gómez-Barreno, L., et al. (2020) Anxiety and Depression in Patients with Confirmed and Suspected COVID-19 in Ecuador. Psychiatry and Clinical Neurosciences, 74, 554-555. https://doi.org/10.1111/pcn.13106
|
[105]
|
Mirfazeli, F.S., Sarabi-Jamab, A., Jahanbakhshi, A., Kordi, A., Javadnia, P., Shariat, S.V., et al. (2020) Neuropsychiatric Manifestations of COVID-19 Can Be Clustered in Three Distinct Symptom Categories. Scientific Reports, 10, Article No. 20957. https://doi.org/10.1038/s41598-020-78050-6
|
[106]
|
Voruz, P., Allali, G., Benzakour, L., Nuber-Champier, A., Thomasson, M., Jacot, I., et al. (2021) Long COVID Neuropsychological Deficits after Severe, Moderate or Mild infection. https://doi.org/10.1101/2021.02.24.21252329
|
[107]
|
Gong, Y., Zhang, L. and Sun, Y. (2021) Correction: More than Just a Mental Stressor: Psychological Value of Social Distancing in COVID-19 Mitigation through Increased Risk Perception—A Preliminary Study in China. Humanities & Social Sciences Communications, 8, Article No. 277. https://doi.org/10.1057/s41599-021-00962-z
|
[108]
|
Atkinson-Clement, C. and Pigalle, E. (2021) What Can We Learn from Covid-19 Pandemic’s Impact on Human Behaviour? The Case of France’s Lockdown. Humanities and Social Sciences Communications, 8, Article No. 81. https://doi.org/10.1057/s41599-021-00749-2
|
[109]
|
Al-Aly, Z., Xie, Y. and Bowe, B. (2021) High-Dimensional Characterization of Post-Acute Sequelae of COVID-19. Nature, 594, 259-264. https://doi.org/10.1038/s41586-021-03553-9
|
[110]
|
Santabárbara, J., Lasheras, I., Lipnicki, D.M., Bueno-Notivol, J., Pérez-Moreno, M., López-Antón, R., et al. (2021) Prevalence of Anxiety in the COVID-19 Pandemic: An Updated Meta-Analysis of Community-Based Studies. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 109, Article ID: 110207. https://doi.org/10.1016/j.pnpbp.2020.110207
|
[111]
|
Arino, H., Heartshorne, R., Michael, B.D., Nicholson, T.R., Vincent, A., Pollak, T.A. and Vogrig, A. (2022) Neuroimmune Disorders in COVID-19. Journal of Neurology, 269, 2827-2839. https://doi.org/10.1007/s00415-022-11050-w
|
[112]
|
Anand, K.S. and Dhikav, V. (2012) Hippocampus in Health and Disease: An Overview. Annals of Indian Academy of Neurology, 15, 239-246. https://doi.org/10.4103/0972-2327.104323
|
[113]
|
Yamamoto, J., Suh, J., Takeuchi, D. and Tonegawa, S. (2014) Successful Execution of Working Memory Linked to Synchronized High-Frequency Gamma Oscillations. Cell, 157, 845-857. https://doi.org/10.1016/j.cell.2014.04.009
|
[114]
|
Nouraeinejad A. (2023) The Functional and Structural Changes in the Hippocampus of COVID-19 Patients. Acta Neurologica Belgica, 123, 1247-1256. https://doi.org/10.1007/s13760-023-02291-1
|
[115]
|
Soung, A.L., Vanderheiden, A., Nordvig, A.S., Sissoko, C.A., Canoll, P., Mariani, M.B., et al. (2022) COVID-19 Induces CNS Cytokine Expression and Loss of Hippocampal Neurogenesis. Brain, 145, 4193-4201. https://doi.org/10.1093/brain/awac270
|
[116]
|
Bayat, A.H., Azimi, H., Hassani Moghaddam, M., Ebrahimi, V., Fathi, M., Vakili, K., et al. (2022) COVID-19 Causes Neuronal Degeneration and Reduces Neurogenesis in Human Hippocampus. Apoptosis, 27, 852-868. https://doi.org/10.1007/s10495-022-01754-9
|
[117]
|
Zhu, B., Wang, Z.G., Ding, J., Liu, N., Wang, D.M., Ding, L.C. and Yang, C. (2014) Chronic Lipopolysaccharide Exposure Induces Cognitive Dysfunction without Affecting BDNF Expression in the Rat Hippocampus. Experimental and Therapeutic Medicine, 7, 750-754. https://doi.org/10.3892/etm.2014.1479
|
[118]
|
Woo, M.S., Malsy, J., Pottgen, J., Seddiq Zai, S., Ufer, F., Hadjilaou, A., et al. (2020) Frequent Neurocognitive Deficits after Recovery from Mild COVID-19. Brain Communications, 2, fcaa205. https://doi.org/10.1093/braincomms/fcaa205
|
[119]
|
Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., Gu, X., et al. (2021) 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. The Lancet, 397, 220-232. https://doi.org/10.1016/S0140-6736(20)32656-8
|
[120]
|
Madjid, M., Safavi-Naeini, P., Solomon, S.D. and Vardeny, O. (2020) Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology, 5, 831-840. https://doi.org/10.1001/jamacardio.2020.1286
|
[121]
|
Liu, P.P., Blet, A., Smyth, D. and Li, H. (2020) The Science Underlying COVID-19: Implications for the Cardiovascular System. Circulation, 142, 68-78. https://doi.org/10.1161/CIRCULATIONAHA.120.047549
|
[122]
|
Meng, L., Qiu, H., Wan, L., Ai, Y., Xue, Z., Guo, Q., et al. (2020) Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan’s Experience. Anesthesiology, 132, 1317-1332. https://doi.org/10.1097/ALN.0000000000003296
|
[123]
|
Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E. and Zafrani, L. (2020) Acute Kidney Injury in Critically Ill Patients with COVID-19. Intensive Care Medicine, 46, 1339-1348. https://doi.org/10.1007/s00134-020-06153-9
|
[124]
|
Pan, X.W., Xu, D., Zhang, H., Zhou, W., Wang, L.H. and Cui, X.G. (2020) Identification of a Potential Mechanism of Acute Kidney Injury during the COVID-19 Outbreak: A Study Based on Single-Cell Transcriptome Analysis. Intensive Care Medicine, 46, 1114-1116. https://doi.org/10.1007/s00134-020-06026-1
|
[125]
|
Bramante, C.T., Ingraham, N.E., Murray, T.A., Marmor, S., Hovertsen, S., Gronski, J., et al. (2021) Metformin and Risk of Mortality in Patients Hospitalised with COVID-19: A Retrospective Cohort Analysis. The Lancet Healthy Longevity, 2, e34-e41. https://doi.org/10.1016/S2666-7568(20)30033-7
|
[126]
|
Rogers, J.P., Chesney, E., Oliver, D., Pollak, T.A., McGuire, P., Fusar-Poli, P., et al. (2020) Psychiatric and Neuropsychiatric Presentations Associated with Severe Coronavirus Infections: A Systematic Review and Meta-Analysis with Comparison to the COVID-19 Pandemic. The Lancet Psychiatry, 7, 611-627. https://doi.org/10.1016/S2215-0366(20)30203-0
|
[127]
|
Pal, R. and Banerjee, M. (2020) COVID-19 and the Endocrine System: Exploring the Unexplored. Journal of Endocrinological Investigation, 43, 1027-1031. https://doi.org/10.1007/s40618-020-01276-8
|
[128]
|
Marazuela, M., Giustina, A. and Puig-Domingo, M. (2020) Endocrine and Metabolic Aspects of the COVID-19 Pandemic. Reviews in Endocrine and Metabolic Disorders, 21, 495-507. https://doi.org/10.1007/s11154-020-09569-2
|
[129]
|
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., et al. (2020) Diabetes Is a Risk Factor for the Progression and Prognosis of COVID-19. Diabetes/Metabolism Research and Reviews, 36, e3319. https://doi.org/10.1002/dmrr.3319
|
[130]
|
Zhai, Z., Li, C., Chen, Y., Gerotziafas, G., Zhang, Z., Wan, J., et al. (2020) Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines. Thrombosis and Haemostasis, 120, 937-948. https://doi.org/10.1055/s-0040-1710019
|
[131]
|
Rahmati, M., Shamsi, M.M., Woo, W., Koyanagi, A., Lee, S.W., Yon, D.K., et al. (2023) Effects of Physical Rehabilitation Interventions in COVID-19 Patients Following Discharge from Hospital: A Systematic Review. Journal of Integrative Medicine, 21, 149-158. https://doi.org/10.1016/j.joim.2023.01.003
|
[132]
|
Puchner, B., Sahanic, S., Kirchmair, R., Pizzini, A., Sonnweber, B., Woll, E., et al. (2021) Beneficial Effects of Multi-Disciplinary Rehabilitation in Postacute COVID-19: An Observational Cohort Study. European Journal of Physical and Rehabilitation Medicine, 57, 189-198.
|
[133]
|
Nambi, G., Abdelbasset, W.K., Alrawaili, S.M., Elsayed, S.H., Verma, A., Vellaiyan, A., et al. (2022) Comparative Effectiveness Study of Low versus High-Intensity Aerobic Training with Resistance Training in Community-Dwelling Older Men with Post-COVID 19 Sarcopenia: A Randomized Controlled Trial. Clinical Rehabilitation, 36, 59-68. https://doi.org/10.1177/02692155211036956
|
[134]
|
Kamal, M., Abo Omirah, M., Hussein, A. and Saeed, H. (2021) Assessment and Characterisation of Post-COVID-19 Manifestations. International Journal of Clinical Practice, 75, e13746. https://doi.org/10.1111/ijcp.13746
|
[135]
|
Oronsky, B., Larson, C., Hammond, T.C., Oronsky, A., Kesari, S., Lybeck, M. and Reid, T.R. (2023) A Review of Persistent Post.
|